Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

JANXJANX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in JANUX THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 952,675 shares of JANX (JANUX THERAPEUTICS INC), worth $14.6M as of 2026-Q2. The position was increased (+58.3% shares). JANX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$14.6M

Current Shares

952,675

Total Value Change

-$5.7M

Total Shares Change

+572,328

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
952,675
+58.3%
$14.6M0.0%$15.36
40
2026-Q1
Decreased
602,013
-43.9%
$8.4M0.0%$13.44
0
2025-Q4
Increased
1.1M
+63.9%
$14.8M0.0%$13.83
41
2025-Q3
Increased
655,108
+88.0%
$16M0.0%$23.70
44
2025-Q2
Increased
348,490
+21.7%
$8.1M0.0%$23.15
33
2025-Q1
Decreased
286,278
-24.7%
$7.7M0.0%$29.10
0
2024-Q4
New
380,347
-
$20.4M0.0%$52.50
39

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used